{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T22:13:09Z","timestamp":1793743989558,"version":"4.6.1"},"reference-count":45,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100008322","name":"CSL Behring","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008322","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["AI158519"],"award-info":[{"award-number":["AI158519"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R21 AI151496"],"award-info":[{"award-number":["R21 AI151496"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["UO1 AI123337"],"award-info":[{"award-number":["UO1 AI123337"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001245","name":"Jeffrey Modell Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001245","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["annallergy.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annals of Allergy, Asthma & Immunology"],"published-print":{"date-parts":[[2022,11]]},"DOI":"10.1016\/j.anai.2022.05.028","type":"journal-article","created":{"date-parts":[[2022,6,6]],"date-time":"2022-06-06T02:01:22Z","timestamp":1654480882000},"page":"572-578","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":20,"title":["Specific antibody deficiency: pearls and pitfalls for diagnosis"],"prefix":"10.1016","volume":"129","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6450-3182","authenticated-orcid":false,"given":"Monica G.","family":"Lawrence","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Larry","family":"Borish","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.anai.2022.05.028_bib0001","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1007\/s10875-019-00737-x","article-title":"Human inborn errors of immunity: 2019 update on the classification from the international union of immunological societies expert committee","volume":"40","author":"Tangye","year":"2020","journal-title":"J Clin Immunol"},{"issue":"1","key":"10.1016\/j.anai.2022.05.028_bib0002","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1007\/s10875-020-00758-x","article-title":"Human inborn errors of immunity: 2019 update of the IUIS phenotypical classification","volume":"40","author":"Bousfiha","year":"2020","journal-title":"J Clin Immunol"},{"issue":"3 suppl","key":"10.1016\/j.anai.2022.05.028_bib0003","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1016\/j.jaci.2012.07.002","article-title":"Use and interpretation of diagnostic vaccination in primary immunodeficiency: a working group report of the Basic and Clinical Immunology Interest Section of the American Academy of Allergy, Asthma & Immunology","volume":"130","author":"Orange","year":"2012","journal-title":"J Allergy Clin Immunol"},{"issue":"5","key":"10.1016\/j.anai.2022.05.028_bib0004","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1016\/j.jaci.2015.04.049","article-title":"Practice parameter for the diagnosis and management of primary immunodeficiency","volume":"136","author":"Bonilla","year":"2015","journal-title":"J Allergy Clin Immunol"},{"issue":"2","key":"10.1016\/j.anai.2022.05.028_bib0005","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1007\/s10875-020-00841-3","article-title":"Immunoglobulin replacement therapy versus antibiotic prophylaxis as treatment for incomplete primary antibody deficiency","volume":"41","author":"Smits","year":"2021","journal-title":"J Clin Immunol"},{"key":"10.1016\/j.anai.2022.05.028_bib0006","doi-asserted-by":"crossref","first-page":"586","DOI":"10.3389\/fimmu.2017.00586","article-title":"Specific antibody deficiency: controversies in diagnosis and management","volume":"8","author":"Perez","year":"2017","journal-title":"Front Immunol"},{"issue":"3","key":"10.1016\/j.anai.2022.05.028_bib0007","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1111\/cei.12915","article-title":"When to initiate immunoglobulin replacement therapy (IGRT) in antibody deficiency: a practical approach","volume":"188","author":"Jolles","year":"2017","journal-title":"Clin Exp Immunol"},{"issue":"3","key":"10.1016\/j.anai.2022.05.028_bib0008","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/S0022-3476(78)80417-X","article-title":"Transient hypogammaglobulinemia of infancy: review of the literature, clinical and immunologic features of 11 new cases, and long-term follow-up","volume":"92","author":"Tiller","year":"1978","journal-title":"J Pediatr"},{"issue":"2","key":"10.1016\/j.anai.2022.05.028_bib0009","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1111\/cei.12571","article-title":"Value of allohaemagglutinins in the diagnosis of a polysaccharide antibody deficiency","volume":"180","author":"Schaballie","year":"2015","journal-title":"Clin Exp Immunol"},{"issue":"1","key":"10.1016\/j.anai.2022.05.028_bib0010","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1007\/s10875-019-00691-8","article-title":"Defining polysaccharide antibody deficiency: measurement of anti-pneumococcal antibodies and anti-salmonella typhi antibodies in a cohort of patients with recurrent infections","volume":"40","author":"Bucciol","year":"2020","journal-title":"J Clin Immunol"},{"issue":"5","key":"10.1016\/j.anai.2022.05.028_bib0011","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1016\/S1081-1206(10)60572-8","article-title":"Assessment and clinical interpretation of polysaccharide antibody responses","volume":"99","author":"Paris","year":"2007","journal-title":"Ann Allergy Asthma Immunol"},{"issue":"2","key":"10.1016\/j.anai.2022.05.028_bib0012","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1111\/j.1365-2567.2004.01971.x","article-title":"Haemophilus influenzae type b conjugate vaccines","volume":"113","author":"Kelly","year":"2004","journal-title":"Immunology"},{"issue":"6","key":"10.1016\/j.anai.2022.05.028_bib0013","doi-asserted-by":"crossref","first-page":"1336","DOI":"10.1016\/j.jaci.2006.09.036","article-title":"Validation of current joint American Academy of Allergy, Asthma & Immunology and American College of Allergy, Asthma and Immunology guidelines for antibody response to the 23-valent pneumococcal vaccine using a population of HIV-infected children","volume":"118","author":"Kamchaisatian","year":"2006","journal-title":"J Allergy Clin Immunol"},{"issue":"5","key":"10.1016\/j.anai.2022.05.028_bib0014","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1016\/j.anai.2019.08.012","article-title":"Antibody deficiency testing for primary immunodeficiency: a practical review for the clinician","volume":"123","author":"Marsh","year":"2019","journal-title":"Ann Allergy Asthma Immunol"},{"issue":"2","key":"10.1016\/j.anai.2022.05.028_bib0015","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/S0091-6749(98)70089-2","article-title":"Influence of age on the response to Streptococcus pneumoniae vaccine in patients with recurrent infections and normal immunoglobulin concentrations","volume":"102","author":"Sorensen","year":"1998","journal-title":"J Allergy Clin Immunol"},{"issue":"2","key":"10.1016\/j.anai.2022.05.028_bib0016","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1007\/s10875-012-9806-9","article-title":"Serotype-specific anti-pneumococcal IgG and immune competence: critical differences in interpretation criteria when different methods are used","volume":"33","author":"Balloch","year":"2013","journal-title":"J Clin Immunol"},{"issue":"1 Pt 1","key":"10.1016\/j.anai.2022.05.028_bib0017","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/0091-6749(93)90303-W","article-title":"Defective antipneumococcal polysaccharide antibody response in children with recurrent respiratory tract infections","volume":"91","author":"Sanders","year":"1993","journal-title":"J Allergy Clin Immunol"},{"issue":"3","key":"10.1016\/j.anai.2022.05.028_bib0018","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1111\/j.1365-2249.2006.03242.x","article-title":"The clinical syndrome of specific antibody deficiency in children","volume":"146","author":"Boyle","year":"2006","journal-title":"Clin Exp Immunol"},{"issue":"3","key":"10.1016\/j.anai.2022.05.028_bib0019","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1111\/pai.13026","article-title":"Using only a subset of pneumococcal serotypes is reliable for the diagnosis of specific antibody deficiency in children: a proof-of-concept study","volume":"30","author":"Kitcharoensakkul","year":"2019","journal-title":"Pediatr Allergy Immunol"},{"issue":"4","key":"10.1016\/j.anai.2022.05.028_bib0020","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/S1081-1206(10)60035-X","article-title":"Preimmunization and postimmunization pneumococcal antibody titers in children with recurrent infections","volume":"76","author":"Hidalgo","year":"1996","journal-title":"Ann Allergy Asthma Immunol"},{"issue":"2","key":"10.1016\/j.anai.2022.05.028_bib0021","first-page":"125","article-title":"Selective deficiency in pneumococcal antibody response in children with recurrent infections","volume":"75","author":"Epstein","year":"1995","journal-title":"Ann Allergy Asthma Immunol"},{"issue":"4","key":"10.1016\/j.anai.2022.05.028_bib0022","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.1016\/j.jaci.2018.06.013","article-title":"Questioning the accuracy of currently available pneumococcal antibody testing","volume":"142","author":"Hajjar","year":"2018","journal-title":"J Allergy Clin Immunol"},{"issue":"3","key":"10.1016\/j.anai.2022.05.028_bib0023","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1016\/j.jaci.2018.10.057","article-title":"Interlaboratory variability in multiplexed pneumococcal antibody testing","volume":"143","author":"LaFon","year":"2019","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.anai.2022.05.028_bib0024","unstructured":"US Food and Drug Administration. Vaccines licensed for use in the United States. 2022. Available at: https:\/\/www.fda.gov\/vaccines-blood-biologics\/vaccines\/vaccines-licensed-use-united-states. Accessed June 16, 2022."},{"issue":"9","key":"10.1016\/j.anai.2022.05.028_bib0025","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1128\/CVI.00112-06","article-title":"Development and validation of a 4-fold multiplexed opsonization assay (MOPA4) for pneumococcal antibodies","volume":"13","author":"Burton","year":"2006","journal-title":"Clin Vaccin Immunol"},{"issue":"8","key":"10.1016\/j.anai.2022.05.028_bib0026","doi-asserted-by":"crossref","first-page":"1964","DOI":"10.1007\/s10875-021-01126-z","article-title":"Pneumococcal antibody function for immunologic evaluation: normal results in older adults, and a novel analytical model for vaccine response","volume":"41","author":"LaFon","year":"2021","journal-title":"J Clin Immunol"},{"key":"10.1016\/j.anai.2022.05.028_bib0027","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jim.2018.05.013","article-title":"Measurement and interpretation of Salmonella typhi Vi IgG antibodies for the assessment of adaptive immunity","volume":"459","author":"Parker","year":"2018","journal-title":"J Immunol Methods"},{"issue":"5","key":"10.1016\/j.anai.2022.05.028_bib0028","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1007\/s10875-017-0406-6","article-title":"The use of Salmonella typhim vaccine to diagnose antibody deficiency","volume":"37","author":"Bausch-Jurken","year":"2017","journal-title":"J Clin Immunol"},{"key":"10.1016\/j.anai.2022.05.028_bib0029","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.clim.2016.05.006","article-title":"Multicenter study for the evaluation of the antibody response against Salmonella typhi Vi vaccination (EMPATHY) for the diagnosis of anti-polysaccharide antibody production deficiency in patients with primary immunodeficiency","volume":"169","author":"Sanchez-Ramon","year":"2016","journal-title":"Clin Immunol"},{"key":"10.1016\/j.anai.2022.05.028_bib0030","doi-asserted-by":"crossref","first-page":"654","DOI":"10.3389\/fimmu.2019.00654","article-title":"Measurement of typhim Vi IgG as a diagnostic tool to determine anti-polysaccharide antibody production deficiency in children","volume":"10","author":"Guevara-Hoyer","year":"2019","journal-title":"Front Immunol"},{"issue":"5","key":"10.1016\/j.anai.2022.05.028_bib0031","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1016\/j.anai.2019.07.014","article-title":"Autoimmunity in common variable immunodeficiency","volume":"123","author":"Agarwal","year":"2019","journal-title":"Ann Allergy Asthma Immunol"},{"issue":"1-3","key":"10.1016\/j.anai.2022.05.028_bib0032","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1007\/s12026-007-0024-0","article-title":"Common variable immune deficiency: reviews, continued puzzles, and a new registry","volume":"38","author":"Cunningham-Rundles","year":"2007","journal-title":"Immunol Res"},{"issue":"7","key":"10.1016\/j.anai.2022.05.028_bib0033","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1007\/s10875-019-00674-9","article-title":"30-year review of pediatric- and adult-onset CVID: clinical correlates and prognostic indicators","volume":"39","author":"Baloh","year":"2019","journal-title":"J Clin Immunol"},{"issue":"5","key":"10.1016\/j.anai.2022.05.028_bib0034","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1111\/j.1526-4610.2004.04094.x","article-title":"Understanding the patient with migraine: the evolution from episodic headache to chronic neurologic disease. A proposed classification of patients with headache","volume":"44","author":"Cady","year":"2004","journal-title":"Headache"},{"issue":"7","key":"10.1016\/j.anai.2022.05.028_bib0035","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1111\/j.1526-4610.1995.hed3507397.x","article-title":"Triggers of headache episodes and coping responses of headache diagnostic groups","volume":"35","author":"Scharff","year":"1995","journal-title":"Headache"},{"issue":"5","key":"10.1016\/j.anai.2022.05.028_bib0036","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.1016\/j.jaci.2016.05.041","article-title":"Diversity of TH cytokine profiles in patients with chronic rhinosinusitis: a multicenter study in Europe, Asia, and Oceania","volume":"138","author":"Wang","year":"2016","journal-title":"J Allergy Clin Immunol"},{"issue":"5","key":"10.1016\/j.anai.2022.05.028_bib0037","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1016\/j.jaci.2015.12.1324","article-title":"Inflammatory endotypes of chronic rhinosinusitis based on cluster analysis of biomarkers","volume":"137","author":"Tomassen","year":"2016","journal-title":"J Allergy Clin Immunol"},{"issue":"8","key":"10.1016\/j.anai.2022.05.028_bib0038","doi-asserted-by":"crossref","first-page":"2812","DOI":"10.1016\/j.jaip.2019.05.009","article-title":"Associations between inflammatory endotypes and clinical presentations in chronic rhinosinusitis","volume":"7","author":"Stevens","year":"2019","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"10","key":"10.1016\/j.anai.2022.05.028_bib0039","doi-asserted-by":"crossref","first-page":"2262","DOI":"10.1002\/lary.21969","article-title":"Evidence for distinct histologic profile of nasal polyps with and without eosinophilia","volume":"121","author":"Payne","year":"2011","journal-title":"Laryngoscope"},{"issue":"4","key":"10.1016\/j.anai.2022.05.028_bib0040","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1016\/j.jaci.2011.05.022","article-title":"Genetics and phenotyping in chronic sinusitis","volume":"128","author":"Payne","year":"2011","journal-title":"J Allergy Clin Immunol"},{"issue":"6","key":"10.1016\/j.anai.2022.05.028_bib0041","doi-asserted-by":"crossref","first-page":"3262","DOI":"10.4049\/jimmunol.171.6.3262","article-title":"Cytokine milieu of atopic dermatitis, as compared to psoriasis, skin prevents induction of innate immune response genes","volume":"171","author":"Nomura","year":"2003","journal-title":"J Immunol"},{"issue":"3","key":"10.1016\/j.anai.2022.05.028_bib0042","doi-asserted-by":"crossref","first-page":"1763","DOI":"10.4049\/jimmunol.172.3.1763","article-title":"Selective killing of vaccinia virus by LL-37: implications for eczema vaccinatum","volume":"172","author":"Howell","year":"2004","journal-title":"J Immunol"},{"issue":"4","key":"10.1016\/j.anai.2022.05.028_bib0043","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1016\/j.jaci.2004.07.013","article-title":"Staphylococcus aureus colonization and IgE antibody formation to enterotoxins is increased in nasal polyposis","volume":"114","author":"Van Zele","year":"2004","journal-title":"J Allergy Clin Immunol"},{"issue":"6","key":"10.1016\/j.anai.2022.05.028_bib0044","doi-asserted-by":"crossref","first-page":"1506","DOI":"10.1016\/j.jaci.2012.03.044","article-title":"Rhinovirus 16-induced IFN-\u03b1 and IFN-\u03b2 are deficient in bronchoalveolar lavage cells in asthmatic patients","volume":"129","author":"Sykes","year":"2012","journal-title":"J Allergy Clin Immunol"},{"issue":"20","key":"10.1016\/j.anai.2022.05.028_bib0045","doi-asserted-by":"crossref","first-page":"2082","DOI":"10.1056\/NEJMoa044113","article-title":"Asthma as a risk factor for invasive pneumococcal disease","volume":"352","author":"Talbot","year":"2005","journal-title":"N Engl J Med"}],"container-title":["Annals of Allergy, Asthma & Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1081120622004951?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1081120622004951?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T13:30:18Z","timestamp":1761053418000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1081120622004951"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11]]},"references-count":45,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2022,11]]}},"alternative-id":["S1081120622004951"],"URL":"https:\/\/doi.org\/10.1016\/j.anai.2022.05.028","relation":{},"ISSN":["1081-1206"],"issn-type":[{"value":"1081-1206","type":"print"}],"subject":[],"published":{"date-parts":[[2022,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Specific antibody deficiency: pearls and pitfalls for diagnosis","name":"articletitle","label":"Article Title"},{"value":"Annals of Allergy, Asthma & Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.anai.2022.05.028","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 American College of Allergy, Asthma & Immunology. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}